Skip to the page

Data / Drug companies / Guaifenesin, dextromethorphan hbr

Guaifenesin, dextromethorphan hbr: 26 companies and 36 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Guaifenesin, dextromethorphan hbr is listed in the FDA National Drug Code Directory by 26 companies, with 36 products in commercial distribution. 29 of the products (80.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, extended release; liquid, and the newest product started marketing on June 16, 2026.

The request: Get every company that lists guaifenesin, dextromethorphan hbr in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
26
Products
36
Generic (ANDA) products
29 (80.6%)
Application numbers
5
Routes
Oral
Brand names
Mucus Relief DM, Mucus Relief DM Extended Release Caplets, Mucus Relief DM, Mucus Relief DM Maximum Strength, NeoTuss S/F Grape-Menthol Flavor, Mucus Relief - DM Maximum Strength, Mucus Relief DM Extended Release Caplets Maximum Strength, Defensol Adult Syrup
openFDA record search
api.fda.gov

Companies that list guaifenesin, dextromethorphan hbr

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
H E B3tablet, extended releaseGeneric drugs (ANDA)March 15, 2023
Doral Pharmamedics Inc DBA A.G. Marin Pharmaceuticals2liquidOver the counter monograph drugsMarch 6, 2025
Family Dollar (family Wellness)2tablet, extended releaseGeneric drugs (ANDA)April 1, 2025
Retail Business Services, LLC2tabletGeneric drugs (ANDA)July 23, 2021
Rite Aid Corporation2tabletGeneric drugs (ANDA)May 31, 2019
Strategic Sourcing Services LLC2tablet, extended releaseGeneric drugs (ANDA)March 31, 2023
Valu Merchandisers Company2tabletGeneric drugs (ANDA)January 14, 2022
Walgreen Company2tabletGeneric drugs (ANDA)January 1, 2019
Yyba Corp2tablet, extended release; tabletGeneric drugs (ANDA)June 16, 2026
A-S Medication Solutions1tabletGeneric drugs (ANDA)November 5, 2018
Advanced Rx LLC1tabletOver the counter monograph drugsJanuary 1, 2025
Atlantic Biologicals Corp.1tablet, extended releaseGeneric drugs (ANDA)December 13, 2018
Bi-Mart1tabletOver the counter monograph drugsJune 1, 2025
CVS Pharmacy1tablet, extended releaseGeneric drugs (ANDA)May 3, 2018
Cardinal Health 110, LLC. DBA Leader1tabletGeneric drugs (ANDA)December 31, 2018
Chain Drug Consortium, LLC1tabletGeneric drugs (ANDA)November 29, 2019
Chain Drug Marketing Association1tabletGeneric drugs (ANDA)December 31, 2018
Dolgencorp, Inc. (dollar General & Rexall)1tabletGeneric drugs (ANDA)March 31, 2019
Fsa Store Inc.1tablet, extended releaseGeneric drugs (ANDA)December 31, 2023
Menper Distributors, Inc.1liquidOver the counter monograph drugsFebruary 21, 2012
Opmx LLC1capsule, liquid filledOver the counter monograph drugsFebruary 18, 2019
P & L Development, LLC1tabletGeneric drugs (ANDA)December 31, 2018
Rising Pharma Holdings, Inc.1liquidOver the counter monograph drugsDecember 22, 2025
Rugby Laboratories1tablet, extended releaseGeneric drugs (ANDA)December 13, 2018
Wal-Mart Stores Inc1tabletGeneric drugs (ANDA)November 29, 2019
WinCo Foods, LLC1tabletGeneric drugs (ANDA)September 1, 2019

Dosage forms

Dosage formProductsShare
Tablet1952.8%
Tablet, extended release1233.3%
Liquid411.1%
Capsule, liquid filled12.8%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)2980.6%
Over the counter monograph drugs719.4%

Pharmacologic classes

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.